Irit Zalayet
Finanzdirektor/CFO bei Pharma Two B Ltd.
Profil
Irit Zalayet is currently the Chief Financial Officer at Pharma Two B Ltd.
and Stem Cell Medicine Ltd.
She received her undergraduate and graduate degrees from Bar-Ilan University.
Aktive Positionen von Irit Zalayet
Unternehmen | Position | Beginn |
---|---|---|
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: GenericHealth Technology Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson’s disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel. | Finanzdirektor/CFO | 01.09.2010 |
Stem Cell Medicine Ltd.
Stem Cell Medicine Ltd. Pharmaceuticals: OtherHealth Technology Stemcell Medicine Ltd. develops and commercializes cellular therapies. It develops products from a number of tissue sources, such as adipose tissue stem cells for ischemic indications and from T cells for solid tumor-directed immunotherapies. The company was founded by Ehud Marom in 2010 and is headquartered in Jerusalem, IL. | Finanzdirektor/CFO | 01.01.2012 |
Ausbildung von Irit Zalayet
Bar-Ilan University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: GenericHealth Technology Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson’s disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel. | Health Technology |
Stem Cell Medicine Ltd.
Stem Cell Medicine Ltd. Pharmaceuticals: OtherHealth Technology Stemcell Medicine Ltd. develops and commercializes cellular therapies. It develops products from a number of tissue sources, such as adipose tissue stem cells for ischemic indications and from T cells for solid tumor-directed immunotherapies. The company was founded by Ehud Marom in 2010 and is headquartered in Jerusalem, IL. | Health Technology |